CNXC
Concentrix Corporation·Technology
26.12
8.351%(−2.38)
Market ClosedLast Updated: — ET
52W L: $24.2752W H: $62.14
CNXC NEWS
defenseworld.net
Apr 3
Head to Head Analysis: Concentrix (NASDAQ:CNXC) versus BrightView (NYSE:BV)
BrightView (NYSE: BV - Get Free Report) and Concentrix (NASDAQ: CNXC - Get Free Report) are both small-cap business services companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, dividends, institutional ownership, risk and earnings. Analyst Ratings This is a breakdown of recent
defenseworld.net
Mar 28
Reviewing BrightView (NYSE:BV) & Concentrix (NASDAQ:CNXC)
Concentrix (NASDAQ: CNXC - Get Free Report) and BrightView (NYSE: BV - Get Free Report) are both small-cap business services companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, valuation and earnings. Insider and Institutional Ownership 90.3% of Concentrix shares
fool.com
Mar 25
Wall Street Has Soured on Artificial Intelligence (AI). Here's Why That's a Buy Signal for These 2 Stocks in 2026.
AI skepticism doesn't mean no opportunity. These two tickers have value where the market isn't looking.
benzinga.com
Mar 25
These Analysts Cut Their Forecasts On Concentrix Following Q1 Results
Concentrix reported quarterly adjusted earnings of $2.61 per share, which missed the Street estimate of $2.65. Quarterly revenue was $2.500 billion, up by 5.4% year-over-year (Y/Y), above the analyst consensus estimate of $2.492 billion.
seekingalpha.com
Mar 25
Concentrix: Cheap For A Reason, But Still Worth Holding (Downgrade)
Concentrix Corporation is rated Hold as it undergoes a complex, costly transition to AI-driven customer experience solutions, with investor confidence shaken by execution risks. Despite a 5.4% YoY revenue increase and a forward P/E of ~2x, CNXC faces margin pressure, negative Q1 free cash flow, and high leverage, justifying its deep discount. Q2 guidance remains below consensus, and the investment thesis now hinges on a second-half 2026 recovery in margins and cash flows to validate the turnaround.
seekingalpha.com
Mar 25
Why I'm Not Buying Concentrix Even At Less Than 3x Earnings
Concentrix trades at extremely low valuation multiples, but its deep value is tempered by significant debt concerns. Concentrix continues to post organic revenue growth, though guidance for FY'26 was modestly below consensus on both the top and bottom lines. GAAP profitability and cash flow are materially lower than non-GAAP figures. Debt service further constrains shareholder returns.
